drugset / Trial / NCT01590199
Evaluate Safety and Tolerability of Pasireotide LAR in Combination With Everolimus in Advanced Metastatic NETs
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This study will evaluate long-term safety and tolerability of pasireotide LAR in combination with everolimus in advanced metastatic NET patients, who who have not progressed during 12 months of combination therapy with pasireotide LAR and everolimus
Timeline
- Start
- 2012-05-18
- Primary completion
- 2018-09-11
- Completion
- 2018-09-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Everolimus | Small molecule | — | — |
| Subject | Pasireotide | Other / unclassified | — | — |